abstract |
The invention provides PDE9 inhibitory compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R, R, R and R are as defined herein. Also provided are pharmaceutical compositions containing compounds of formula I and their use in the treatment of neurodegenerative and cognitive disorders, such as Alzheimer's disease and schizophrenia. |